on 23 Jan 2024
Last Applicant/ Owned by
161 Oyster Point Blvd
South San Francisco
CA
94080
Serial Number
90701065 filed on 10th May 2021
Registration Number
7287794 registered on 23rd Jan 2024
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer Read More
Medical services for the prevention of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the localization of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for the localization of cancer; Medical services for the therapy of cancer in humans, namely, medical assay processing provided by medical laboratories and medical analysis services for treating cancer; Medical services for the prevention of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detecting cancer; Medical services for the detection of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for detection of cancer; Medical services for the therapy of cancer in animals, namely, medical assay processing provided by medical laboratories and medical analysis services for the treatment of cancer
05th Oct 2022
05th Oct 2022
Products for the prevention of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the localization of cancer in humans, namely, pharmaceutical products to express a synthetic biomarker for localization of cancer; Products for the therapy of cancer in humans, namely, pharmaceutical products to express a treatment agent for treating cancer; Products for the prevention of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the detection of cancer in animals, namely, pharmaceutical products to express a synthetic biomarker for detecting cancer; Products for the therapy of cancer in animals, namely, pharmaceutical products to express a treatment agent for treating cancer
04th Jan 2023
24th Jan 2023
No 90701065
No Service Mark
No 413.T002
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
23rd Jan 2024 | REGISTERED-PRINCIPAL REGISTER |
23rd Jan 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
19th Dec 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
18th Dec 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
07th Dec 2023 | ASSIGNED TO LIE |
07th Dec 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
07th Dec 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
07th Jul 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
10th Apr 2023 | SU - NON-FINAL ACTION - WRITTEN |
10th Apr 2023 | NON-FINAL ACTION E-MAILED |